Variant report

Variant	esv1819320
Chromosome Location	chr19:35848565-35865695
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:210)
CpG islands
(count:368)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:210 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr19:35849261-35849449	K562	blood:	n/a	n/a
2	BACH1	chr19:35851866-35852079	K562	blood:	n/a	n/a
3	CEBPB	chr19:35849017-35849385	IMR90	lung:	n/a	chr19:35849192-35849203
4	CEBPB	chr19:35864499-35864730	K562	blood:	n/a	n/a
5	CEBPB	chr19:35849029-35849356	A549	lung:	n/a	chr19:35849192-35849203
6	CEBPB	chr19:35849037-35849249	K562	blood:	n/a	chr19:35849192-35849203
7	CEBPB	chr19:35849083-35849292	H1-hESC	embryonic stem cell:	n/a	chr19:35849192-35849203
8	CEBPB	chr19:35849027-35849357	HepG2	liver:	n/a	chr19:35849192-35849203
9	CEBPB	chr19:35864457-35864718	HepG2	liver:	n/a	n/a
10	CEBPB	chr19:35849039-35849353	Hela-S3	cervix:	n/a	chr19:35849192-35849203
11	CEBPB	chr19:35861266-35861524	A549	lung:	n/a	chr19:35861400-35861411
12	CEBPB	chr19:35861291-35861545	IMR90	lung:	n/a	chr19:35861400-35861411
13	CEBPB	chr19:35861320-35861547	K562	blood:	n/a	chr19:35861400-35861411
14	CEBPB	chr19:35849025-35849368	K562	blood:	n/a	chr19:35849192-35849203
15	CEBPB	chr19:35861294-35861521	HepG2	liver:	n/a	chr19:35861400-35861411
16	CTCF	chr19:35862487-35862490	MCF-7	breast:	n/a	n/a
17	CTCF	chr19:35849819-35849993	H1-hESC	embryonic stem cell:	n/a	n/a
18	CTCF	chr19:35848580-35848730	HEK293	kidney:	n/a	n/a
19	CTCF	chr19:35849840-35849990	GM06990	blood:	n/a	n/a
20	CTCF	chr19:35862400-35862454	GM20000	blood:	n/a	n/a
21	CTCF	chr19:35849780-35849930	SK-N-SH_RA	brain:	n/a	n/a
22	CTCF	chr19:35862328-35862517	Fibrobl	skin:	n/a	n/a
23	CTCF	chr19:35849840-35849990	GM12866	blood:	n/a	n/a
24	CTCF	chr19:35862417-35862550	GM13977	blood:	n/a	n/a
25	CTCF	chr19:35862340-35862508	A549	lung:	n/a	n/a
26	CTCF	chr19:35848660-35848810	MCF-7	breast:	n/a	n/a
27	CTCF	chr19:35849840-35849990	GM12868	blood:	n/a	n/a
28	CTCF	chr19:35849627-35849703	H1-hESC	embryonic stem cell:	n/a	n/a
29	CTCF	chr19:35849780-35849930	GM12875	blood:	n/a	n/a
30	CTCF	chr19:35862329-35862490	GM19238	blood:	n/a	n/a
31	CTCF	chr19:35849798-35850068	GM13977	blood:	n/a	n/a
32	CTCF	chr19:35849858-35849961	HepG2	liver:	n/a	n/a
33	CTCF	chr19:35849874-35849999	Hela-S3	cervix:	n/a	n/a
34	CTCF	chr19:35849780-35849930	GM12874	blood:	n/a	n/a
35	CTCF	chr19:35862115-35862183	GM13976	blood:	n/a	n/a
36	CTCF	chr19:35849748-35850042	K562	blood:	n/a	n/a
37	CTCF	chr19:35850172-35850235	GM12891	blood:	n/a	n/a
38	CTCF	chr19:35849800-35849950	GM12867	blood:	n/a	n/a
39	CTCF	chr19:35849882-35850011	Kidney_OC	kidney:	n/a	n/a
40	CTCF	chr19:35862354-35862464	Hela-S3	cervix:	n/a	n/a
41	CTCF	chr19:35862325-35862487	K562	blood:	n/a	n/a
42	CTCF	chr19:35851457-35851512	GM12891	blood:	n/a	n/a
43	CTCF	chr19:35862518-35862521	Fibrobl	skin:	n/a	n/a
44	CTCF	chr19:35849780-35849930	K562	blood:	n/a	n/a
45	CTCF	chr19:35862336-35862493	MCF-7	breast:	n/a	n/a
46	CTCF	chr19:35862296-35862574	GM19239	blood:	n/a	n/a
47	CTCF	chr19:35849861-35850024	ProgFib	skin:	n/a	n/a
48	CTCF	chr19:35862239-35862573	H1-hESC	embryonic stem cell:	n/a	n/a
49	CTCF	chr19:35849868-35850029	A549	lung:	n/a	n/a
50	CTCF	chr19:35862198-35862537	K562	blood:	n/a	n/a

(count:368 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:35850463-35850513	AoSMC	blood vessel:	n/a
2	chr19:35850463-35850513	AG04450	lung:	fetal
3	chr19:35850463-35850513	AoSMC	blood vessel:	n/a
4	chr19:35850463-35850513	AG04450	lung:	fetal
5	chr19:35848801-35848851	BJ	skin:	n/a
6	chr19:35848801-35848851	GM12878	blood:	n/a
7	chr19:35849024-35849074	GM06990	blood:	n/a
8	chr19:35850463-35850513	HCF	heart:	n/a
9	chr19:35848801-35848851	NB4	blood:	n/a
10	chr19:35861862-35861912	HIPEpiC	eye:	n/a
11	chr19:35849176-35849226	HIPEpiC	eye:	n/a
12	chr19:35861862-35861912	SKMC	muscle:	n/a
13	chr19:35849024-35849074	MCF-7	breast:	n/a
14	chr19:35849176-35849226	A549	lung:	n/a
15	chr19:35850463-35850513	RPTEC	kidney:	n/a
16	chr19:35849393-35849443	NHDF-neo	bronchial:	n/a
17	chr19:35850463-35850513	Hepatocyte	liver:	n/a
18	chr19:35849393-35849443	BE2_C	brain:	n/a
19	chr19:35850463-35850513	BJ	skin:	n/a
20	chr19:35849393-35849443	AG09309	skin:	n/a
21	chr19:35849393-35849443	Hela-S3	cervix:	n/a
22	chr19:35849393-35849443	GM12891	blood:	n/a
23	chr19:35849176-35849226	NH-A	brain:	n/a
24	chr19:35849024-35849074	AG10803	skin:	n/a
25	chr19:35849024-35849074	SKMC	muscle:	n/a
26	chr19:35848801-35848851	GM12891	blood:	n/a
27	chr19:35861862-35861912	HCF	heart:	n/a
28	chr19:35850463-35850513	T-47D	breast:	n/a
29	chr19:35849393-35849443	HNPCEpiC	eye:	n/a
30	chr19:35849393-35849443	HIPEpiC	eye:	n/a
31	chr19:35849024-35849074	HAEpiC	amniotic membrane:	n/a
32	chr19:35861862-35861912	Jurkat	blood:	n/a
33	chr19:35849176-35849226	HRCEpiC	kidney:	n/a
34	chr19:35849024-35849074	ProgFib	skin:	n/a
35	chr19:35849024-35849074	HNPCEpiC	eye:	n/a
36	chr19:35848801-35848851	HAEpiC	amniotic membrane:	n/a
37	chr19:35849024-35849074	RPTEC	kidney:	n/a
38	chr19:35861862-35861912	MCF10A-Er-Src	breast:	n/a
39	chr19:35861862-35861912	NT2-D1	testis:	n/a
40	chr19:35849393-35849443	NH-A	brain:	n/a
41	chr19:35849024-35849074	BE2_C	brain:	n/a
42	chr19:35861862-35861912	AG09319	gingival:	n/a
43	chr19:35849024-35849074	SK-N-SH	brain:	n/a
44	chr19:35850463-35850513	HIPEpiC	eye:	n/a
45	chr19:35849393-35849443	SK-N-MC	brain:	n/a
46	chr19:35848801-35848851	CMK	blood:	n/a
47	chr19:35850463-35850513	H1-hESC	embryonic stem cell:	embryo
48	chr19:35849393-35849443	T-47D	breast:	n/a
49	chr19:35848801-35848851	Hela-S3	cervix:	n/a
50	chr19:35849393-35849443	NB4	blood:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:35847716..35849933-chr19:35855045..35856568,2	MCF-7	breast:
2	chr19:35865310..35868154-chr19:35869837..35872073,2	K562	blood:
3	chr19:35864467..35867206-chr19:35939200..35941045,2	MCF-7	breast:

No data

Variant related genes	Relation type
FFAR3	TF binding region
GPR42	TF binding region
FFAR3	CpG island
GPR42	CpG island
ENSG00000126262	chromatin interactions
ENSG00000185897	chromatin interactions

Extended variants
information (count: 505 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:505 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs146957350	chr19:35848567-35848568	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs117325178	chr19:35848581-35848582	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs144608354	chr19:35848585-35848586	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs556012300	chr19:35848590-35848591	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs551612974	chr19:35848648-35848649	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs571655164	chr19:35848681-35848682	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs572545638	chr19:35848684-35848685	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs534119242	chr19:35848705-35848706	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs148483143	chr19:35848718-35848719	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs374551699	chr19:35848801-35848802	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs564308596	chr19:35848802-35848803	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs533405847	chr19:35848830-35848831	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs60182696	chr19:35848858-35848859	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs533676772	chr19:35848866-35848867	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs12608878	chr19:35848867-35848868	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs147554474	chr19:35848883-35848884	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs142490306	chr19:35848923-35848924	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs7251096	chr19:35848955-35848956	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs113192141	chr19:35848956-35848957	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs551493036	chr19:35848969-35848970	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs140872408	chr19:35848996-35848997	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs17272288	chr19:35849061-35849062	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
23	rs367544251	chr19:35849136-35849137	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs537004693	chr19:35849143-35849144	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs537890763	chr19:35849176-35849177	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
26	rs143244108	chr19:35849183-35849184	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs58199607	chr19:35849184-35849185	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs536178273	chr19:35849273-35849274	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs146704794	chr19:35849283-35849284	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs555975639	chr19:35849306-35849307	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs572634896	chr19:35849343-35849344	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs381099	chr19:35849410-35849411	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs375854528	chr19:35849428-35849429	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs369874702	chr19:35849436-35849437	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
35	rs558280055	chr19:35849441-35849442	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs10412120	chr19:35849447-35849448	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs539350244	chr19:35849471-35849472	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs543374650	chr19:35849472-35849473	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs59198030	chr19:35849563-35849564	Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs62109580	chr19:35849666-35849667	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs369303830	chr19:35849690-35849691	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs573573596	chr19:35849691-35849692	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs542544927	chr19:35849738-35849739	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs368520877	chr19:35849742-35849743	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs528333217	chr19:35849755-35849756	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs146397125	chr19:35849813-35849814	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs551288253	chr19:35849824-35849825	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs368567016	chr19:35849841-35849842	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs371169601	chr19:35849849-35849850	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs530535002	chr19:35849856-35849857	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	21397856	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Liver carcinoma	19366792	CNVD
Ovarian cancer	20844748	CNVD
Non-small cell lung cancer	21829676	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Cancer	21183584	CNVD
Honadal dysgenesis	21048976	CNVD
Neurodevelopmental disorder	22521361	CNVD
Endometrial cancer	23636398	CNVD
Disorders of sex development	21048976	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Gastric cancer	21811585	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Multiple myeloma	17550852	CNVD
Lung cancer	18438408	CNVD
Glioma	17123091	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Lung cancer	21569311	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:101 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:35838200-35849200	Weak transcription	Brain Hippocampus Middle	brain
2	chr19:35839200-35848600	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
3	chr19:35839200-35848800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
4	chr19:35843800-35848600	Weak transcription	Gastric	stomach
5	chr19:35844000-35848800	Weak transcription	Primary hematopoietic stem cells	blood
6	chr19:35844000-35849000	Weak transcription	Ovary	ovary
7	chr19:35844000-35849000	Weak transcription	Spleen	Spleen
8	chr19:35844200-35848800	Weak transcription	Primary T helper cells fromperipheralblood	blood
9	chr19:35844200-35849000	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
10	chr19:35844200-35849000	Weak transcription	Primary T killer memory cells from peripheral blood	blood
11	chr19:35844600-35849000	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
12	chr19:35846400-35848800	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
13	chr19:35847200-35848600	Weak transcription	Adipose Nuclei	Adipose
14	chr19:35847200-35848800	Weak transcription	Liver	Liver
15	chr19:35847200-35852000	Weak transcription	GM12878-XiMat	blood
16	chr19:35847600-35848600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
17	chr19:35847600-35848600	Weak transcription	Fetal Lung	lung
18	chr19:35847600-35848800	Weak transcription	Fetal Muscle Trunk	muscle
19	chr19:35848200-35848800	Enhancers	Primary neutrophils fromperipheralblood	blood
20	chr19:35848200-35849200	Enhancers	Pancreatic Islets	Pancreatic Islet
21	chr19:35848200-35849400	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
22	chr19:35848200-35849600	Enhancers	Primary monocytes fromperipheralblood	blood
23	chr19:35848400-35848800	Enhancers	Monocytes-CD14+_RO01746	blood
24	chr19:35848400-35849000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
25	chr19:35848400-35849400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
26	chr19:35848400-35849400	Enhancers	Primary T helper naive cells from peripheral blood	blood
27	chr19:35848400-35849400	Enhancers	Primary T helper cells PMA-I stimulated	--
28	chr19:35848400-35849400	Enhancers	Fetal Muscle Leg	muscle
29	chr19:35848400-35849400	Enhancers	HepG2	liver
30	chr19:35848400-35849600	Enhancers	Primary hematopoietic stem cells short term culture	blood
31	chr19:35848400-35849600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
32	chr19:35848400-35849600	Enhancers	Placenta	Placenta
33	chr19:35848600-35848800	Enhancers	Adipose Nuclei	Adipose
34	chr19:35848600-35849000	Enhancers	Fetal Lung	lung
35	chr19:35848600-35849200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
36	chr19:35848600-35849400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
37	chr19:35848600-35849400	Enhancers	Gastric	stomach
38	chr19:35848600-35849400	Enhancers	Pancreas	Pancrea
39	chr19:35848800-35849000	Enhancers	Fetal Intestine Large	intestine
40	chr19:35848800-35849200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
41	chr19:35848800-35849200	Enhancers	Fetal Brain Female	brain
42	chr19:35848800-35849200	Enhancers	Fetal Muscle Trunk	muscle
43	chr19:35848800-35849200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
44	chr19:35848800-35849200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
45	chr19:35848800-35849400	Enhancers	ES-I3 Cell Line	embryonic stem cell
46	chr19:35848800-35849400	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr19:35848800-35849400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
48	chr19:35848800-35849400	Flanking Active TSS	Adipose Nuclei	Adipose
49	chr19:35848800-35849400	Enhancers	Liver	Liver
50	chr19:35848800-35849400	Enhancers	Brain Germinal Matrix	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links